1-2 of 2
Jeffrey Chell
Close
Sort by
Journal Articles

Feasibility of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission: Results of the Transplant Objective from the SWOG (S1203) Randomized Phase III Study of Induction Therapy Using Standard 7+3 Therapy or Idarubicin with High-Dose Cytarabine (IA) Versus IA Plus Vorinostat

John M. Pagel, MD PhD, Megan Othus, PhD, Guillermo Garcia-Manero, MD, Min Fang, Jerald P. Radich, MD, David A. Rizzieri, MD, Guido Marcucci, MD, Stephen A. Strickland, Mark Litzow, MD, Mary Lynn Savoie, MD FRCPC, Stephen R. Spellman, MBS, Dennis L. Confer, MD, Jeffrey Chell, MD, Maria Brown, Bruno C. Medeiros, MD, Mikkael A. Sekeres, MD MS, Tara L. Lin, Geoffrey L. Uy, MD, Bayard L Powell, MD, Jonathan E. Kolitz, MD, Richard A. Larson, MD, Richard M. Stone, MD, David F. Claxton, MD, James Essell, MD, Selina Luger, MD, Sanjay R. Mohan, MD, Anna Moseley, Harry P. Erba, MD PhD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2016) 128 (22): 1166.
https://doi.org/10.1182/blood.V128.22.1166.1166
Published: 2016
Journal Articles

Establishment of the NMDP Cord Blood Banking Network.

Joanne Kurtzberg, MD, Michael Creer, MD, PhD, Mary Halet, Kathy Welte, John E. Wagner, MD, Michael Boo, Dennis L. Confer, MD, Jeffrey Chell
Journal: Blood
Blood (2004) 104 (11): 5190.
https://doi.org/10.1182/blood.V104.11.5190.5190
Published: 2004